Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Eukaryotic translation elongation factor 1 alpha 1 pseudogene 39 (EEF1A1P39) is classified as a pseudogene, meaning it is a non-functional genomic sequence related to the protein-coding gene EEF1A1, which encodes a component of the translation elongation complex involved in protein synthesis. Pseudogenes like EEF1A1P39 are generally considered non-coding and do not produce functional proteins. There is no evidence in current databases that EEF1A1P39 acts as a therapeutic target, possesses well-characterized biological functions, or is implicated as a biomarker or drug target. Most EEF1A1 pseudogenes, including EEF1A1P39, are not well characterized, and there is no evidence that EEF1A1P39 is relevant to disease mechanisms or drug response at present. EEF1A1P39 is a pseudogene, not an active receptor, enzyme, transporter, or transcription factor. The parental gene, EEF1A1, encodes elongation factor 1-alpha 1, a well-studied protein essential for translation; however, pseudogenes derived from EEF1A1 (such as EEF1A1P39) are typically non-functional remnants with no known protein product or therapeutic relevance. Some EEF1A1 pseudogenes have been tentatively linked to disease studies via association or expression-level changes, but there is no evidence for functional or druggable activity in EEF1A1P39 specifically. EEF1A1P39 has not been identified as a target for any approved or experimental drug, nor has it been identified as a clinical biomarker, disease gene, or therapeutic safety concern. EEF1A1P39 is a pseudogene with no evidence supporting its role as a therapeutic target, disease gene, or biomarker. Its listing as a "target" is incorrect; it is best classified as non-functional genomic DNA related to the EEF1A1 gene.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Eukaryotic translation elongation factor 1 alpha 1 pseudogene 39 (EEF1A1P39).